
A Modern Approach to Global Growth & Compliance in Life Sciences: A Story of Digitalization at Boehringer Ingelheim
As an active global player, Boehringer Ingelheim has digitally transformed critical aspects of their business in order to remain an innovative leader in the life sciences industry. Hear how to gain alignment, coordination, and collaboration across global teams to digitally transform your business one department at a time while navigating complex and evolving mix of global regulations. Live: Wednesday, Nov. 13, 2019 at 2pm EST | 1pm CST | 11am PST On demand available after airing until Nov. 13, 2020 Register free
Register free:
Event Overview:
Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and has a global workforce of over 50,000 employees. As an active global player, Boehringer Ingelheim has digitally transformed critical aspects of their business in order to remain an innovative leader in the life sciences industry.
Don’t miss this insightful webcast where you’ll learn how to continue to grow your global business while reducing your risk exposure with a modern global system of agreement that allows you to automate and connect systems.
Key Learning Objectives:
- Hear best practices about how to gain alignment, coordination, and collaboration across global teams to digitally transform a business unit across the US, Australia, Asia Pacific, and Europe
- See how Boehringer Ingelheim successfully integrated across DocuSign, SAP Successfactors, and developed global standards for IT
- Learn how to digitally transform your business - one department at a time while navigating complex and evolving global regulations
- Get ideas on how to digitally transform a contract management system and Part 11 regulated use cases
Time and Date: Wednesday, Nov. 13, 2019 at 2pm EST | 1pm CST | 11am PST
On demand available after airing until Nov. 13, 2020
Sponsor: DocuSign
Register free:
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.